{"database": "openregs", "table": "documents", "is_view": false, "human_description_en": "where docket_id = \"FDA-2012-D-0307\" and posted_year = 2020 sorted by posted_date descending", "rows": [["FDA-2012-D-0307-0064", "FDA", "FDA-2012-D-0307", "Recommendations to Reduce the Possible Risk of Transmission of Creutzfeldt-Jakob Disease and Variant Creutzfeldt-Jakob Disease by Blood and Blood Components", "Other", "Guidance", "2020-06-17T04:00:00Z", 2020, 6, "2020-06-17T04:00:00Z", null, "2024-11-06T23:37:22Z", null, 1, 0, "09000064846f63b5"], ["FDA-2012-D-0307-0063", "FDA", "FDA-2012-D-0307", "Recommendations To Reduce the Possible Risk of Transmission of\nCreutzfeldt-Jakob Disease and Variant Creutzfeldt Jakob Disease by Blood and Blood Components; Guidance for Industry; Availability;", "Notice", "Notice of Availability", "2020-06-17T04:00:00Z", 2020, 6, "2020-06-17T04:00:00Z", null, "2020-06-17T12:33:02Z", "2020-13055", 0, 0, "09000064846f5d22"], ["FDA-2012-D-0307-0055", "FDA", "FDA-2012-D-0307", "Recommendations to Reduce the Possible Risk of Transmission of Creutzfeldt-Jakob Disease and Variant Creutzfeldt-Jakob Disease by Blood and Blood Components Guidance for Industry", "Other", "Guidance", "2020-04-03T04:00:00Z", 2020, 4, "2020-04-03T04:00:00Z", null, "2024-11-06T23:34:05Z", null, 1, 0, "090000648448596f"], ["FDA-2012-D-0307-0056", "FDA", "FDA-2012-D-0307", "29 Reference 29 Holmquest et al. No evidence of transfusion transmitted sporadic CJD", "Supporting & Related Material", "Background Material", "2020-04-03T04:00:00Z", 2020, 4, null, null, "2020-04-03T14:35:47Z", null, 0, 0, "09000064844859c1"], ["FDA-2012-D-0307-0037", "FDA", "FDA-2012-D-0307", "Reference 26- Development of Dose-Response Models of Creutzfeldt-Jakob Disease Infection in Nonhuman Primates re Amendment to \u2018\u2018Revised Preventive Measures To Reduce the Possible Risk of Transmission of Creutzfeldt-Jakob Disease and Variant Creutzfeldt-Jakob Disease by Blood and Blood Products; Guidance for Industry;\u2019\u2019 Draft Guidance for Industry; Availability", "Supporting & Related Material", "Background Material", "2020-02-25T05:00:00Z", 2020, 2, null, null, "2020-02-25T16:03:56Z", null, 0, 0, "09000064843ae6d8"], ["FDA-2012-D-0307-0038", "FDA", "FDA-2012-D-0307", "Reference 33- The New England Journal of Medicine re Amendment to \u2018\u2018Revised Preventive Measures To Reduce the Possible Risk of Transmission of Creutzfeldt-Jakob Disease and Variant Creutzfeldt-Jakob Disease by Blood and Blood Products; Guidance for Industry;\u2019\u2019 Draft Guidance for Industry; Availability", "Supporting & Related Material", "Background Material", "2020-02-25T05:00:00Z", 2020, 2, null, null, "2020-02-25T16:04:02Z", null, 0, 0, "09000064843ae6d7"], ["FDA-2012-D-0307-0031", "FDA", "FDA-2012-D-0307", "Recommendations To Reduce the Possible Risk of Transmission of Creutzfeldt-Jakob Disease and Variant Creutzfeldt Jakob Disease by Blood and Blood Components;  Draft Guidance for Industry; Availability", "Notice", "Notice of Availability", "2020-01-31T05:00:00Z", 2020, 1, "2020-01-31T05:00:00Z", "2020-04-01T03:59:59Z", "2020-02-25T13:29:12Z", "2020-01815", 0, 0, "0900006484315e30"], ["FDA-2012-D-0307-0032", "FDA", "FDA-2012-D-0307", "Recommendations to Reduce the Possible Risk of Transmission of Creutzfeldt-Jakob Disease and Variant Creutzfeldt-Jakob Disease by Blood and Blood Components; Draft Guidance for Industry", "Other", "Guidance", "2020-01-30T05:00:00Z", 2020, 1, "2020-01-30T05:00:00Z", null, "2024-11-12T23:16:48Z", null, 1, 0, "0900006484317192"]], "truncated": false, "filtered_table_rows_count": 8, "expanded_columns": [], "expandable_columns": [[{"column": "docket_id", "other_table": "dockets", "other_column": "id"}, "title"]], "columns": ["id", "agency_id", "docket_id", "title", "document_type", "subtype", "posted_date", "posted_year", "posted_month", "comment_start_date", "comment_end_date", "last_modified", "fr_doc_num", "open_for_comment", "withdrawn", "object_id"], "primary_keys": ["id"], "units": {}, "query": {"sql": "select id, agency_id, docket_id, title, document_type, subtype, posted_date, posted_year, posted_month, comment_start_date, comment_end_date, last_modified, fr_doc_num, open_for_comment, withdrawn, object_id from documents where \"docket_id\" = :p0 and \"posted_year\" = :p1 order by posted_date desc limit 101", "params": {"p0": "FDA-2012-D-0307", "p1": "2020"}}, "facet_results": {"agency_id": {"name": "agency_id", "type": "column", "hideable": false, "toggle_url": "/openregs/documents.json?docket_id=FDA-2012-D-0307&posted_year=2020", "results": [{"value": "FDA", "label": "FDA", "count": 8, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2012-D-0307&posted_year=2020&agency_id=FDA", "selected": false}], "truncated": false}, "document_type": {"name": "document_type", "type": "column", "hideable": false, "toggle_url": "/openregs/documents.json?docket_id=FDA-2012-D-0307&posted_year=2020", "results": [{"value": "Other", "label": "Other", "count": 3, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2012-D-0307&posted_year=2020&document_type=Other", "selected": false}, {"value": "Supporting & Related Material", "label": "Supporting & Related Material", "count": 3, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2012-D-0307&posted_year=2020&document_type=Supporting+%26+Related+Material", "selected": false}, {"value": "Notice", "label": "Notice", "count": 2, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2012-D-0307&posted_year=2020&document_type=Notice", "selected": false}], "truncated": false}, "posted_year": {"name": "posted_year", "type": "column", "hideable": false, "toggle_url": "/openregs/documents.json?docket_id=FDA-2012-D-0307&posted_year=2020", "results": [{"value": 2020, "label": 2020, "count": 8, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2012-D-0307", "selected": true}], "truncated": false}}, "suggested_facets": [{"name": "subtype", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2012-D-0307&posted_year=2020&_facet=subtype"}, {"name": "posted_date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2012-D-0307&posted_year=2020&_facet=posted_date"}, {"name": "posted_month", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2012-D-0307&posted_year=2020&_facet=posted_month"}, {"name": "comment_start_date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2012-D-0307&posted_year=2020&_facet=comment_start_date"}, {"name": "open_for_comment", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2012-D-0307&posted_year=2020&_facet=open_for_comment"}, {"name": "posted_date", "type": "date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2012-D-0307&posted_year=2020&_facet_date=posted_date"}, {"name": "comment_start_date", "type": "date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2012-D-0307&posted_year=2020&_facet_date=comment_start_date"}, {"name": "comment_end_date", "type": "date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2012-D-0307&posted_year=2020&_facet_date=comment_end_date"}, {"name": "last_modified", "type": "date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2012-D-0307&posted_year=2020&_facet_date=last_modified"}], "next": null, "next_url": null, "private": false, "allow_execute_sql": true, "query_ms": 1062.169107957743, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}